Quetiapine
Product Images NDC 67046-622

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 67046-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Tablets 100 mg (Quetiapine 100mg 30)

Label for Quetiapine 100 mg tablets, bottle of 30, labeled by Contract Pharmacy Services-PA. The label includes storage instructions at 25°C (77°F) with permitted excursions, prescription status (Rx Only), lot number P14428, pill ID Q 100, and an expiration date of 11/07/15. It specifies each film-coated tablet contains Quetiapine Fumarate equivalent to 100 mg Quetiapine.*

FDA Label Image

Quetiapine Tablets 200 mg (Quetiapine 200mg 30)

Label for Quetiapine 200 mg tablets, package count 30, supplied by Contract Pharmacy Services-PA. The label displays dosage strength, quantity, lot number, expiration date, storage instructions, and barcodes. It states each film-coated tablet contains Quetiapine Fumarate equivalent to 200 mg of Quetiapine.*

FDA Label Image

Quetiapine Tablets 300 mg (Quetiapine 300mg 30)

Label for Quetiapine 300 mg tablets, pack of 30, labeled by Contract Pharmacy Services-PA. The label includes storage instructions, stating to store at 25°C (77°F) with permitted excursions to 15-30°C (59-86°F). Each film-coated tablet contains Quetiapine Fumarate equivalent to 300 mg Quetiapine. The label also has barcodes, lot number R00724, and expiration date 11/07/15.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

A line chart showing the proportion of patients with relapse (%) over time (weeks), with two plotted groups labeled QTP + LI/VAL and PLA + LI/VAL. The chart compares relapse rates between these two groups over a period extending to approximately 100 weeks.*

FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

A Kaplan-Meier curve chart showing the proportion of patients with relapse (%) over time in weeks. It compares two groups: one treated with QTP+ Li/VAL and the other with PLA+ Li/VAL. Time on the x-axis ranges from 0 to 100 weeks, and the y-axis shows relapse percentage from 0 to 100%, with QTP+ Li/VAL group exhibiting a lower relapse rate over time compared to PLA+ Li/VAL group.*

FDA Label Image

Chemstructure (Quetiapine Str)

Chemical structure diagram showing the molecular formula of Quetiapine, including its core tricyclic ring system with attached functional groups and a counter ion structure. The drawing depicts the two-part ionic compound form relevant to Quetiapine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.